Literature DB >> 18563520

Current status of coronary artery bypass grafting.

Junjiro Kobayashi1.   

Abstract

The number of cases of coronary artery bypass grafting (CABG) reached more than 21 000 in Japan in 2002, and the operative mortality decreased to less than 1%, including emergency operations. The annual number of CABGs in Japan declined 17% after 2003 to 18 000 cases in 2005 owing to unrestricted percutaneous coronary intervention (PCI) with drug-eluting stents. However, CABG is the best treatment for multivessel coronary artery disease based on the comparative data of PCI versus CABG. There have been two trends in CABG during the last decade. One is the widespread use of off-pump (OP) CABG, and the other is multiple coronary artery revascularization. In 2004 and 2005, approximately 60% of all isolated CABG procedures in Japan were performed without cardiopulmonary bypass. In a study of long-term outcomes comparing PCI with drug-eluting stents versus CABG with only arterial grafts, the latter was carried out in 52% of total cases and in 66% of OPCAB cases. OPCAB with multiple arterial grafts has become the standard CABG in Japan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563520     DOI: 10.1007/s11748-008-0251-x

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  87 in total

1.  Bilateral skeletonized internal thoracic artery grafts in patients with diabetes mellitus.

Authors:  M Matsa; Y Paz; J Gurevitch; I Shapira; A Kramer; D Pevny; R Mohr
Journal:  J Thorac Cardiovasc Surg       Date:  2001-04       Impact factor: 5.209

2.  Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

Authors:  Patrick W Serruys; Andrew T L Ong; Lex A van Herwerden; J Eduardo Sousa; Adib Jatene; Johannes J R M Bonnier; Jacques P M A Schönberger; Nigel Buller; Robert Bonser; Clemens Disco; Bianca Backx; Paul G Hugenholtz; Brian G Firth; Felix Unger
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

3.  Midterm results after minimally invasive coronary surgery (LAST operation)

Authors:  A M Calafiore; G Di Giammarco; G Teodori; S Gallina; N Maddestra; L Paloscia; G Scipioni; T Iovino; M Contini; G Vitolla
Journal:  J Thorac Cardiovasc Surg       Date:  1998-04       Impact factor: 5.209

4.  A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

Authors:  S B King; N J Lembo; W S Weintraub; A S Kosinski; H X Barnhart; M H Kutner; N P Alazraki; R A Guyton; X Q Zhao
Journal:  N Engl J Med       Date:  1994-10-20       Impact factor: 91.245

5.  Alternative approach to multivessel coronary disease with integrated coronary revascularization.

Authors:  M Zenati; H A Cohen; B P Griffith
Journal:  J Thorac Cardiovasc Surg       Date:  1999-03       Impact factor: 5.209

6.  Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes.

Authors:  Mark D Peterson; Michael A Borger; Vivek Rao; Charles M Peniston; Christopher M Feindel
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

7.  Revival of the radial artery for coronary artery bypass grafting.

Authors:  C Acar; V A Jebara; M Portoghese; B Beyssen; J Y Pagny; P Grare; J C Chachques; J N Fabiani; A Deloche; J L Guermonprez
Journal:  Ann Thorac Surg       Date:  1992-10       Impact factor: 4.330

8.  Radial artery patency: are aortocoronary conduits superior to composite grafting?

Authors:  Hersh S Maniar; Hendrick B Barner; Marci S Bailey; Sunil M Prasad; Marc R Moon; Michael K Pasque; Martha L Lester; William A Gay; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2003-11       Impact factor: 4.330

9.  Internal thoracic artery grafts: 20-year clinical follow-up.

Authors:  A A Cameron; G E Green; D A Brogno; J Thornton
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

10.  Off-Pump Coronary Artery Bypass Using Skeletonized Gastroepiploic Artery, a Pilot Study.

Authors:  Atsushi Amano; Ruzheng Li; Hitoshi Hirose
Journal:  Heart Surg Forum       Date:  2004-01-01       Impact factor: 0.676

View more
  4 in total

Review 1.  The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review.

Authors:  Stephen A May; James M Wilson
Journal:  Tex Heart Inst J       Date:  2009

Review 2.  Changing strategy for aortic stenosis with coronary artery disease by transcatheter aortic valve implantation.

Authors:  Junjiro Kobayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-04-02

3.  The future of off-pump coronary artery bypass grafting: a North American perspective.

Authors:  Bobby Yanagawa; Rashmi Nedadur; John D Puskas
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

4.  Resveratrol inhibits angiotensin II-induced ERK1/2 activation by downregulating quinone reductase 2 in rat vascular smooth muscle cells.

Authors:  Xiwen Zhang; Yao Wang; Weiwei Yang; Xiaofeng Hou; Jiangang Zou; Kejiang Cao
Journal:  J Biomed Res       Date:  2012-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.